Funded Startups in Morrisville
Among the 19 most recent funded entries based in Morrisville, the largest disclosed round is Humacyte’s $50M on 2026-06-10, and it sits close to the top ba…
Among the 19 most recent funded entries based in Morrisville, the largest disclosed round is Humacyte’s $50M on 2026-06-10, and it sits close to the top band with Metabolon at $60M (2024-05-16) and TARGAN at $30M (2026-03-03). By contrast, the smallest disclosed amount is Incredible Eats’ $20K on 2023-05-04, creating a steep spread from the mid-$50M range down to the tens-of-thousands.
Timing is clustered: 3 rounds fall in 2026 (Humacyte on 2026-06-10, TARGAN on 2026-03-03), and most activity is concentrated between 2022-06-13 (SmartSky Networks) and 2024-05-16 (Metabolon), with entries spanning 2021-05-14 through 2026-06-10. Sector-wise, Biotechnology is the most common category, appearing in 5 of the 19 rows (Humacyte, Metabolon, Silversky as IT though, Locus Biosciences, Liquidia Technologies, Arrivo BioVentures LLC, Novan), while “Series Unknown” appears in 11 of 19 rows and “undisclosed” appears once (Silversky, 2024-04-18).
Most recent rounds
19 shownRelated listings
Frequently asked
What stands out in the size of disclosed rounds, and is there a clear outlier?
Humacyte’s $50M (2026-06-10) is near the top of the disclosed range, but the list’s largest disclosed amount is Metabolon’s $60M (2024-05-16); at the low end, Incredible Eats closed at $20K (2023-05-04). This makes the smallest disclosed round an extreme outlier relative to the rest of the disclosed amounts (e.g., $30M at TARGAN on 2026-03-03, $45M at Arrivo BioVentures LLC on 2023-11-29).
How concentrated are deals by date within the Morrisville list shown here?
There’s a visible recent cluster in 2026: two rounds in Q1/Q2 2026 (TARGAN $30M on 2026-03-03; Humacyte $50M on 2026-06-10). Broadly, the dated entries span 2021-05-14 (Gilero) through 2026-06-10 (Humacyte), with a dense middle anchored around 2022–2024 entries like PlayMetrics $5M (2022-08-29), ETON Solutions $38M (2022-07-12), and Metabolon $60M (2024-05-16).
Which stage labels dominate, and how much of the list is not labeled by series?
“Series Unknown” is the dominant classification at 11 of 19 rows, covering entries such as Humacyte (2026-06-10, $50M) and Metabolon (2024-05-16, $60M). Only one row is explicitly “undisclosed” for amount (Silversky on 2024-04-18), while named stages appear in a minority of rows (e.g., Arrivo BioVentures LLC is “Series B” at $45M on 2023-11-29; ETON Solutions is “Series C” at $38M on 2022-07-12).
Are any sectors over-represented compared to others in this Morrisville set?
Biotechnology is the most frequent sector, appearing in 5 of 19 rows (Humacyte, Metabolon, Locus Biosciences, Liquidia Technologies, Arrivo BioVentures LLC, plus Novan and others listed as Biotechnology). Other categories appear less often and in smaller counts (e.g., Data and Analytics includes Data443 on 2023-07-24 and Tactyc on 2022-11-17).
What size or sector patterns show up around the mid-to-late 2023 period?
In 2023, disclosed rounds vary widely but cluster around meaningful funding levels: Arrivo BioVentures LLC raised $45M on 2023-11-29, Novan raised $15M on 2023-07-17, and Spencer Health Solutions raised $6M on 2023-05-02, while Incredible Eats is the sharp downside at $20K on 2023-05-04. The sector mix across those dates includes multiple Biotechnology entries (e.g., Novan and Arrivo) alongside at least one Consumer Goods entry (Incredible Eats).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.